Research

Energy balance

Challenges in ensuring safety, tolerability, and equitable access are critical barriers to advancing anti-obesity pharmacotherapy.

Address these barriers to improve obesity treatment outcomes.

StrongSupportsmedium confidence
However, challenges in ensuring safety, tolerability, and equitable access remain critical barriers.
Jiale Lu et al. · European Journal of Pharmacology · 2025

Why this rating

The claim is based on a review of current challenges in pharmacotherapy.

Source

Recent progress in the pharmacotherapy for obesity

Jiale Lu et al. · European Journal of Pharmacology · 2025

DOI 10.1016/j.ejphar.2025.177850

reviewCited 9×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →